Clinical Trial Update: A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mavacamten for obstructive hypertrophic cardiomyopathy has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Obstructive Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cardiomyopathy, Hypertrophic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2024-12-04